This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Management of regional lymph nodes

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Regional lymph nodes may be excised as a precautionary measure if they are as yet clinically uninvolved - elective lymph node dissection, ELND - or if they are clearly affected - therapeutic lymph node dissection, TLND.

ELND:

  • a controversial area as 22% of malignant melanomas recur at distant sites without regional node involvement
  • no prospective, randomised trials yet exist to show any benefit
  • not generally carried out for stage I disease in the UK
  • may benefit those with back, arm, neck or scalp distribution, who are male and have ulceration, nodularity or acra-lentiginous types

TLND:

  • may be performed before, during or after treatment of the primary
  • indicated in:
    • those with obvious regional node involvement at initial presentation
    • those whose previously normal nodes grow in size

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.